Standout Papers
- Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (2022)
- Robot-assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma: Early Results of a Multicenter Randomized Controlled Trial: the RAMIE Trial. (2022)
Immediate Impact
1 from Science/Nature 51 standout
Citing Papers
A comprehensive review on supercapacitors: Their promise to flexibility, high temperature, materials, design, and challenges
2024 Standout
Targeting the Warburg Effect in Cancer: Where Do We Stand?
2024 Standout
Works of Hezhong Chen being referenced
HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK/mTOR signaling pathway
2020
肺腫瘍化学療法のための経口抗腫瘍薬キャリアとしてのDDAB修飾TPGS-b-(PLC-ran-PGA)ナノ粒子
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Hezhong Chen | 509 | 526 | 491 | 57 | 1.2k | |
| Daniel Kedar | 411 | 541 | 387 | 52 | 1.3k | |
| Christoph Seidel | 561 | 374 | 529 | 68 | 1.2k | |
| Rudolf Schwarz | 377 | 550 | 1039 | 44 | 1.7k | |
| Stéphane Tercier | 520 | 275 | 409 | 40 | 1.2k | |
| Paola Casieri | 378 | 343 | 491 | 43 | 1.4k | |
| Bishoy M. Faltas | 464 | 704 | 491 | 73 | 1.4k | |
| Huabin Yin | 337 | 260 | 467 | 77 | 1.1k | |
| Ulrika Segersten | 522 | 460 | 229 | 36 | 1.2k | |
| Alba Balladelli | 429 | 333 | 1215 | 42 | 1.7k | |
| Heiko Wunderlich | 859 | 409 | 712 | 91 | 1.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...